| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 264,451 | 267,082 | 254,343 | 282,137 | | Cost of Revenue | 120,364 | 122,799 | 111,454 | 119,265 | | | Gross Profit | 144,087 | 144,283 | 142,889 | 162,872 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,401 | 10,109 | 9,599 | 8,831 | | Non Recurring |
-
|
-
|
-
| 1,160 | | Others | 61,311 | 61,085 | 61,848 | 60,889 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (34,135) | 73,089 | 71,442 | 91,992 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,307 | 13,333 | 26,555 |
-
| | Earnings Before Interest And Taxes | 83,584 | 86,422 | 97,997 | 91,992 | | Interest Expense | 34,943 | 35,026 | 36,541 | 36,558 | | Income Before Tax | 48,641 | 51,396 | 61,456 | 55,434 | | Income Tax Expense | 375 | 376 | 373 | 501 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 99,363 | 51,020 | 61,083 | 54,933 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 48,266 | 51,020 | 61,083 | 54,933 | | Preferred Stock And Other Adjustments | (7,470) | (7,470) | (7,470) | (7,470) | | | Net Income Applicable To Common Shares | $40,796 | $43,550 | $53,613 | $47,463 |
|
0.26% Nasdaq 0.00%
Income Statement
